Translate
Immunome Inc
About
Immunome Inc (NASDAQ:IMNM) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Immunome Announces Oral Presentation of Phase 3 RINGSIDE Data at 2026 ASCO Annual Meeting
Mar 3 2026
Immunome Reports Full Year 2025 Financial Results and Provides Business Update
Feb 5 2026
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 4 2026
Immunome to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
Jan 6 2026
Immunome to Present at 44th Annual J.P. Morgan Healthcare Conference
Financials
Revenue
$6.94 M
Market Cap
$2.43 B
EPS
-2.43